Medical Health & Life Science Research News

Infertility services market in US to grow at a CAGR of 4.65% during the period 2017-2021 insights shared in detailed report

Research analysts forecast the infertility services market in US to grow at a CAGR of 4.65% during the period 2017-2021.

- Advertising -

Infertility is the failure to achieve pregnancy after 12 months of unprotected intercourse. Infertility occurs due to the abnormal functioning of the female and male reproductive system.

It can be treated with infertility drugs and through procedures such as artificial insemination, in-vitro fertilization, and surrogacy.

Request sample copy of the report at: www.orbisresearch.com/contacts/request-sample/244699

Covered in this report

The report covers the present scenario and the growth prospects of the infertility services market in US for 2017-2021.

- Advertising -

To calculate the market size, the report considers the services carried out during treatment via infertility drugs and assisted reproductive technology (ART) services.

Research report, Infertility Services Market in US 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years.

The report also includes a discussion of the key vendors operating in this market.

Read more details of the report at: www.orbisresearch.com/reports/index/infertility-services-market-in-us-2017-2021

Key vendors

  • CARE facility
  • CooperSurgical
  • Ferring Pharmaceuticals
  • Monash IVF
  • Merck
  • Vitrolife

Other prominent vendors

  • AbbVie
  • Apricus Biosciences
  • AstraZeneca
  • Auxogyn
  • Eli Lilly
  • EMD Serono
  • IKS International
  • InVitro Care
  • INVO Bioscience
  • Irvine Scientific
  • LifeGlobal
  • MedITEX
  • NMC Health
  • OB GYN Associates
  • OvaScience
  • Pantec Biosolutions
  • Reproductive Medicine Associates of New Jersey
  • The Sims Clinic
  • TriHealth
  • Virtus Health
  • Xytex Cryo International

Market driver

  • Rising success rate of infertility treatments.
  • For a full, detailed list, view our report

Market challenge

  • Limited reimbursements and lack of strict regulatory oversight.
  • For a full, detailed list, view our report

Market trend

  • Upsurge in mergers and acquisitions.
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Companies Mentioned:

CARE facility, CooperSurgical, Ferring Pharmaceuticals, Monash IVF, Merck, Vitrolife, AbbVie, Apricus Biosciences, AstraZeneca, Auxogyn, Eli Lilly, EMD Serono, IKS International, InVitro Care, INVO Bioscience, Irvine Scientific, LifeGlobal, MedITEX, NMC Health, OB GYN Associates, OvaScience, Pantec Biosolutions, Reproductive Medicine Associates of New Jersey, The Sims Clinic, TriHealth, Virtus Health, Xytex Cryo International.

 

 

News From

Orbis Research - Rendering Conscientious ResearchOrbis Research
Category: Market Research Publishers and RetailersCompany profile: Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have a vast database of reports from the leading publishers and authors across the gl obe. We specialize in delivering customised reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialisation. This helps our clients to map their need, and we produce the perfect requi ...